Skip to main content
. Author manuscript; available in PMC: 2014 Dec 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2013 Sep 23;273(3):10.1016/j.taap.2013.09.010. doi: 10.1016/j.taap.2013.09.010

Figure 1.

Figure 1

Plasma ALT activities in mice treated with APAP, 2-APB, or both. Mice were treated with 400 mg/kg APAP or saline (blank control), and 2-APB was co-treated with APAP, or post-treated at 1.5 h, 4.5 h or 6 h after APAP administration with DMSO (0.2 ml/kg, vehicle control) as the solvent for 2-APB. Mice were sacrificed at 6 h (A) or 24 h (B) after APAP administration. Data are expressed as means ± SE, n=3–5 mice per group. *P<0.05 (compared to blank control). #P<0.05 (compared to APAP). $P<0.05 (compared to vehicle control).